ÐÓ°ÉÔ­´´

The Trump administration today steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the lowest cost paid for the same medications in other countries. The steps include providing MFN prices to all Medicaid beneficiaries; requiring manufacturers to stipulate that they will not offer other developed nations better prices for new drugs than those offered in the U.S.; providing manufacturers an avenue to sell medicines directly to patients at a price no higher than the best available in developed nations; and using trade policy to support manufacturers in raising prices internationally provided that higher revenues abroad are reinvested directly into lowering prices for Americans.